Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use
Novel methods of medical treatment and/or inhibition of development of diseases are disclosed for diseases that are sensitive to androgenic or estrogenic activity. The treatments utilize inhibitors of type 5 and/or type 3 17β-hydroxysteroid dehydrogenase. Novel inhibitors of type 5 17β-hydroxysteroid dehydrogenase are also disclosed, as are novel inhibitors of type 3 17β-hydroxysteroid dehydrogenase.
-
(2008/06/13)
PREPARATION OF 6-METHYLPREGNA-4,6-DIENE-3&β,17&α-DIOL-20-ONE 17-CAPROATE AND ITS INFLUENCE ON THE REPRODUCTIVE FUNCTION IN RATS
-
Grinenko, G. S.,Kadatskii, G. M.,Korkhov, V. V.,Boikova, V. V.
p. 718 - 720
(2007/10/02)
Novel 17-esters of 17α-hydroxy gestogens, compositions containing such compounds, processes for their preparation and methods of treatment therewith
This invention relates to novel 17α-esters of gestogens having an antitumour activity and to the preparation thereof. The invention is also concerned with pharmaceutical compositions containing the said compounds, and method of treatment therewith.
-
(2008/06/13)
More Articles about upstream products of 3562-63-8